Panobinostat As Salvage Treatment for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Not Eligible to High Dose Therapy: A Phase II Study of the Fondazione Italiana Linfomi (FIL)

被引:0
|
作者
Zaja, Francesco [1 ]
Volpetti, Stefano [1 ]
Chiappella, Annalisa [2 ]
Salvi, Flavia [3 ]
Carella, Angelo M. [4 ]
Ibatici, Adalberto [4 ]
Piccaluga, Pier Paolo [5 ]
Pileri, Stefano A. [5 ]
Rossi, Davide [6 ]
Zinzani, Pier Luigi [7 ]
Patti, Caterina [8 ]
Vitolo, Umberto [2 ]
D'Arco, Alfonso [9 ]
Tucci, Alessandra [10 ,11 ]
Franceschetti, Silvia [12 ]
Evangelista, Andrea [13 ]
Lenti, Valentina [14 ]
Fanin, Renato [1 ]
Levis, Alessandro [15 ]
机构
[1] Univ Udine, Dipartimento Sci Med Sperimentali & Clin DISM, I-33100 Udine, Italy
[2] SC Ematol Azienda Osped Citta Salute & Sci, Turin, Italy
[3] AO SS Antonio & Biagio & C Arrigo, Alessandria, Italy
[4] IRCCS AOU San Martino IST, UOC Ematol 1, Genoa, Italy
[5] Univ Bologna, Dip Med Specialist Diagnost & Sperimentale, Bologna, Italy
[6] Amedeo Avogadro Univ Eastern Piedmont, Div Hematol, Dept Translat Med, Novara, Italy
[7] Ist Ematol & Oncol Med, Bologna, Italy
[8] Azienda Osped Riuniti Villa Sofia Cervello, Div Ematol, Palermo, Italy
[9] UO Oncoematol Polo Oncol, Nocera Pagani, Italy
[10] Spedali Civil Brescia, SC Ematol, I-25125 Brescia, Italy
[11] Spedali Civil Brescia, Dipartimento Oncol Med, I-25125 Brescia, Italy
[12] Univ Piemonte Orientale Amedeo Avogadro, Div Ematol, Dipartimento Med Traslaz, Novara, Italy
[13] Univ Turin, SCDU Epidemiol Tumori, Turin, Italy
[14] Segreteria Fdn Italiana Linfomi Onlus, Alessandria, Italy
[15] SC Ematol AO SS Antonio & Biagio, Alessandria, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL)
    Tucci, Alessandra
    Merli, Francesco
    Fabbri, Alberto
    Marcheselli, Luigi
    Pagani, Chiara
    Puccini, Benedetta
    Marino, Dario
    Zanni, Manuela
    Pennese, Elsa
    Flenghi, Leonardo
    Arcari, Annalisa
    Botto, Barbara
    Celli, Melania
    Mammi, Caterina
    Re, Alessandro
    Campostrini, Giulia
    Tafuri, Agostino
    Zilioli, Vittorio R.
    Cencini, Emanuele
    Sartori, Roberto
    Bottelli, Chiara
    Merli, Michele
    Petrucci, Luigi
    Gini, Guido
    Balzarotti, Monica
    Cavallo, Federica
    Musuraca, Gerardo
    Luminari, Stefano
    Rossi, Giuseppe
    Spina, Michele
    HAEMATOLOGICA, 2023, 108 (04) : 1083 - 1091
  • [42] The role of radiotherapy as salvage and/or consolidation treatment in relapsed/refractory and high-risk diffuse large B-cell lymphoma
    Grignano, Eric
    Laurent, Jeremy
    Deau, Benedicte
    Burroni, Barbara
    Bouscary, Didier
    Kirova, Youlia M.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (02) : 150 - 159
  • [43] BRENTUXIMAB VEDOTIN IN THE TREATMENT OF RELAPSED/REFRACTORY CD30 POSITIVE PERIPHERAL T-CELL LYMPHOMA PATIENTS: A PHASE 2 STUDY OF THE FONDAZIONE ITALIANA LINFOMI
    Carella, M.
    Pellegrini, C.
    Corradini, P.
    Orsucci, L.
    Volpetti, S.
    Argnani, L.
    Dodero, A.
    Stefoni, V.
    Zinzani, P. L.
    HAEMATOLOGICA, 2021, 106 (10) : 70 - 70
  • [44] A Phase I Study of Copanlisib and Venetoclax in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Crombie, Jennifer L.
    Kim, Austin I.
    Bartlett, Nancy L.
    Redd, Robert A.
    Patterson, Victoria
    Carey, Celeste
    Balasubramanian, Sobana
    Odejide, Oreofe O.
    Merryman, Reid W.
    LaCasce, Ann
    Jacobson, Caron A.
    Jacobsen, Eric
    Parry, Erin M.
    Fisher, David C.
    Herrera, Alex F.
    Davids, Matthew S.
    Shipp, Margaret A.
    Armand, Philippe
    Shouse, Geoffrey P.
    BLOOD, 2023, 142
  • [45] LOW-DOSE ETOPOSIDE AND CYTARABINE: A PALLIATIVE TREATMENT OPTION IN PATIENTS WITH REFRACTORY/RELAPSED DIFFUSE LARGE B CELL LYMPHOMA NOT ELIGIBLE FOR INTENSIVE SALVAGE CHEMOTHERAPY
    Hassan, S.
    Montoto, S.
    Gribben, J.
    De Vos, J.
    HAEMATOLOGICA, 2012, 97 : 654 - 654
  • [47] Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi
    Chiappella, Annalisa
    Tucci, Alessandra
    Castellino, Alessia
    Pavone, Vincenzo
    Baldi, Ileana
    Carella, Angelo Michele
    Orsucci, Lorella
    Zanni, Manuela
    Salvi, Flavia
    Liberati, Anna Marina
    Gaidano, Gianluca
    Bottelli, Chiara
    Rossini, Bernardo
    Perticone, Sonia
    De Masi, Pasqualina
    Ladetto, Marco
    Ciccone, Giovannino
    Palumbo, Antonio
    Rossi, Giuseppe
    Vitolo, Umberto
    HAEMATOLOGICA, 2013, 98 (11) : 1732 - 1738
  • [48] Ibrutinib in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Study
    Ren, Liangliang
    Li, Ling
    Zhang, Lei
    Li, Xin
    Fu, Xiaorui
    Wang, Xinhua
    Wu, Jingjing
    Sun, Zhenchang
    Feng, Xiaoyan
    Chang, Yu
    Zhou, Zhiyuan
    Nan, Feifei
    Yan, Jiaqin
    Kong, Fei
    Zhang, Mingzhi
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2022, 38 (01) : 42 - 50
  • [49] Ibrutinib in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Study
    Liangliang Ren
    Ling Li
    Lei Zhang
    Xin Li
    Xiaorui Fu
    Xinhua Wang
    Jingjing Wu
    Zhenchang Sun
    Xiaoyan Feng
    Yu Chang
    Zhiyuan Zhou
    Feifei Nan
    Jiaqin Yan
    Fei Kong
    Mingzhi Zhang
    Indian Journal of Hematology and Blood Transfusion, 2022, 38 : 42 - 50
  • [50] Copanlisib in Combination with Nivolumab in Subjects with Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma: A Phase II Study
    Bennani, N. Nora
    Atherton, Pamela
    Steinert, Kimberly O.
    Rimsza, Lisa M.
    Tun, Aung M.
    Hoffmann, Marc S.
    Narkhede, Mayur S.
    Vaidya, Rakhee
    Said, Rabih
    Shapiro, Geoffrey I.
    Costello, Brian A.
    Ansell, Stephen M.
    Nowakowski, Grzegorz S.
    BLOOD, 2023, 142